Abstract:Abstract MicroRNAs (miRNAs) are a class of small noncoding RNA molecules containing only 20–22 nucleotides. MiRNAs play a role in gene silencing and translation suppression by targeting and binding to mRNA. Proper control of miRNA expression is very important for maintaining a normal physiological environment because miRNAs can affect most cellular pathways, including cell cycle checkpoint, cell proliferation, and apoptosis pathways, and have a wide range of target genes. With these properties, miRNAs can modulate multiple signalling pathways involved in cancer development, such as cell proliferation, apoptosis, and migration pathways. MiRNAs that activate or inhibit the molecular pathway related to tumour angiogenesis are common topics of research. Angiogenesis promotes tumorigenesis and metastasis by providing oxygen and diffusible nutrients and releasing proangiogenic factors and is one of the hallmarks of tumour progression. CRC is one of the most common tumours, and metastasis has always been a difficult issue in its treatment. Although comprehensive treatments, such as surgery, radiotherapy, chemotherapy, and targeted therapy, have prolonged the survival of CRC patients, the overall response is not optimistic. Therefore, there is an urgent need to find new therapeutic targets to improve CRC treatment. In a series of recent reports, miRNAs have been shown to bidirectionally regulate angiogenesis in colorectal cancer. Many miRNAs can directly act on VEGF or inhibit angiogenesis through other pathways (HIF-1a, PI3K/AKT, etc.), while some miRNAs, specifically many exosomal miRNAs, are capable of promoting CRC angiogenesis. Understanding the mechanism of action of miRNAs in angiogenesis is of great significance for finding new targets for the treatment of tumour angiogenesis. Deciphering the exact role of specific miRNAs in angiogenesis is a challenge due to the high complexity of their actions. Here, we describe the latest advances in the understanding of miRNAs and their corresponding targets that play a role in CRC angiogenesis and discuss possible miRNA-based therapeutic strategies.

New Perspectives in Colorectal Cancers Treatment, the Role of MicroRNAs

MicroRNAs in Colorectal Cancer As Markers and Targets: Recent Advances.

MicroRNAs and colorectal cancer: clinical potential and regulatory networks

The Clinical Significance of MicroRNAs in Colorectal Cancer Signaling Pathways: A Review

Advances in the Treatment of Colorectal Cancer Using MicroRNA

MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside

MicroRNAs and Cancer: Key Paradigms in Molecular Therapy (Review)

Colorectal Cancer: From the Genetic Model to Posttranscriptional Regulation by Noncoding RNAs

MicroRNAs (miRNAs): Novel potential therapeutic targets in colorectal cancer

MicroRNA in Colorectal Cancer: from Benchtop to Bedside

Small molecules targeting microRNAs: new opportunities and challenges in precision cancer therapy

Mast Cells, microRNAs and Others: The Role of Translational Research on Colorectal Cancer in the Forthcoming Era of Precision Medicine

Roles of miRNAs in Colorectal Cancer: Therapeutic Implications and Clinical Opportunities

miRNAs as cornerstones in colorectal cancer pathogenesis and resistance to therapy: A spotlight on signaling pathways interplay - A review

MicroRNAs and angiogenesis: a new era for the management of colorectal cancer

MicroRNAs: Multifaceted Regulators of Colorectal Cancer Metastasis and Clinical Applications

MicroRNAs in colorectal carcinoma--from pathogenesis to therapy

MicroRNAs in colorectal cancer: Small molecules with big functions

MicroRNA and Breast Cancer: Understanding Pathogenesis, Improving Management

&Lt;p>micrornas: Multifaceted Regulators of Colorectal Cancer Metastasis and Clinical Applications</p>

MicroRNAs: Novel Immunotherapeutic Targets in Colorectal Carcinoma.